Atherotech elects Mason as VP of clinical operations
Kaitlyn Dmyterko | December 18, 2009 | Cardiovascular Business | Cardiac Imaging
In a move to expand its disease management and clinician services sectors, cardio-diagnostic developer Atherotech has appointed Jennifer E. Mason, RN, MS, as its vice president of clinical operations.

According to the Birmingham, Ala.-based company, responsibilities will include boosting the educational and outreach efforts for its line of cardiometabolic tests.

Prior to this position, Mason was employed as a clinician at the Berkeley HeartLab since 2001. With her new role, Mason will report to CEO Mike Mullen and work closely with Chief Medical Officer Michael Cobble, MD.

Kaitlyn Dmyterko

Related Content

AI predicts cardiovascular risk during CT scans—no invasive tests or contrast required
New cardiac imaging strategy could reduce ICA, PCI rates
Medicare drops AUC requirement for advanced imaging, ASNC celebrates
GE Healthcare launching new AI software for handheld ultrasound system
Cardiology, radiology groups urge insurance provider to rethink imaging policy
Cardiologists see value in AI-based plaque assessments

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Radiology Business
Philips launches new AI-enabled CT scanner aimed at cardiology at ECR 2024

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Design by Adaptive Theme
Trimed Popup
Trimed Popup